Use of venofer for iron deficiency correction in patients undergoing programmed hemodialysis

摘要: AIM To study iron metabolism in patients on programmed hemodialysis (PH) oral and intravenous administration of drugs; to compare clinical financial results using such drugs. MATERIAL AND METHODS A two-stage trial studied 158 PH replacement therapy with erythropoetin. They received correction deficiency drugs (stage I) venofer II). RESULTS The has found its 2/3 receiving iron: absolute (48%) relative (20%). Administration led a 2-fold increase the number normal metabolism. target Hb Ht were achieved 2.5 times more than before treatment. dose erythpoetin cases was reduced by 40%. Side effects not observed. week cost treatment per patient lower 22.5$ CONCLUSION Venofer is effective both clinically financially use preparations.